The results demonstrated that the PI3K/Akt and HIF-1α signaling pathways were among the top three pathways exhibiting the most significant changes, further emphasizing their importance in sorafenib resistance in HCC. This evidence concerns the gene AKT1 and hepatocellular carcinoma.